Intuitive Surgical, Inc. $ISRG Shares Purchased by Ritholtz Wealth Management

Key Points

• Ritholtz Wealth Management increased its holdings in Intuitive Surgical by 18.9% in Q2, acquiring an additional 895 shares, bringing its total to 5,633 shares valued at approximately $3.06 million.
• Insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical, representing a 59.69% decrease in ownership, while insiders as a whole sold a total of 45,224 shares worth nearly $21.7 million over the past three months.
• Intuitive Surgical reported a 21.4% increase in quarterly revenue year-over-year, with earnings per share of $2.19, surpassing estimates and reflecting strong market performance amid institutional investor interest.

Ritholtz Wealth Management raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 18.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,633 shares of the medical equipment provider's stock after buying an additional 895 shares during the quarter. Ritholtz Wealth Management's holdings in Intuitive Surgical were worth $3,061,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Chilton Capital Management LLC raised its position in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 43 shares during the period. Elite Financial Inc. bought a new position in Intuitive Surgical in the 1st quarter worth approximately $26,000. LFA Lugano Financial Advisors SA bought a new position in Intuitive Surgical in the 1st quarter worth approximately $30,000. TD Capital Management LLC boosted its stake in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 45 shares in the last quarter. Finally, 1248 Management LLC bought a new position in Intuitive Surgical during the 1st quarter valued at $30,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the firm's stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amy L. Ladd sold 336 shares of the firm's stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director owned 1,074 shares in the company, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 over the last three months. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Trading Down 0.2%

Shares of NASDAQ:ISRG opened at $435.61 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The business has a fifty day simple moving average of $456.15 and a 200 day simple moving average of $496.60. The firm has a market cap of $156.16 billion, a price-to-earnings ratio of 60.75, a P/E/G ratio of 4.58 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same period last year, the company earned $1.78 earnings per share. Intuitive Surgical's quarterly revenue was up 21.4% compared to the same quarter last year. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Truist Financial decreased their price target on Intuitive Surgical from $600.00 to $525.00 and set a "buy" rating for the company in a research note on Wednesday. Erste Group Bank reaffirmed a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. The Goldman Sachs Group decreased their price target on Intuitive Surgical from $621.00 to $567.00 and set a "buy" rating for the company in a research note on Wednesday, October 1st. BTIG Research decreased their price target on Intuitive Surgical from $571.00 to $529.00 and set a "buy" rating for the company in a research note on Monday. Finally, Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, October 4th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $582.14.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.